# Assessment of Knowledge, Attitude, and Practice Regarding Topical Corticosteroid Use Among Dermatology Outpatients in a Tertiary Care Hospital: A Cross-Sectional Study

**Authors:** Samiksha Agarwal, Apurva Agrawal

PMC · DOI: 10.7759/cureus.101743 · 2026-01-17

## TL;DR

This study found that many dermatology patients in India lack awareness about the safe and proper use of topical corticosteroids, despite knowing basic application details.

## Contribution

The study provides new insights into patient knowledge, attitudes, and practices regarding topical corticosteroid use in a specific Indian region.

## Key findings

- 70% of participants were unaware of the risks of unsupervised topical corticosteroid use.
- 82% had used topical medications without consulting a healthcare provider.
- High-potency corticosteroids like betamethasone were commonly prescribed.

## Abstract

Introduction: Topical corticosteroids (TC) play a vital role in the treatment of many diseases and have been prescribed extensively. Over-the-counter availability and self‑medication by patients make them one of the most commonly misused medications. As TC misuse is associated with serious adverse effects, it is important to know how much patients are aware of them.

Aim and objective: The aim of this study was to evaluate knowledge, attitude, and practice (KAP) related to TC use among patients attending the dermatology outpatient department of a tertiary care government institute located in southern Rajasthan, India.

Methods: A cross-sectional questionnaire-based study was conducted on patients aged 18 years and above who have been prescribed at least one TC. A total of 100 consenting patients were interviewed on the basis of a structured questionnaire containing 15 questions regarding sociodemographic profile, self-reported knowledge of TC application, use, and misuse.

Result: Of the 100 participants, 60% were male, and 50% belonged to the age group of 18-39 years. Thirty-four (34%) were illiterate, and 39% had only a school education. Dermatitis (37%) was the most common condition, and betamethasone (68%) was the most common TC prescribed. The majority self-reported that they knew the appropriate quantity (88%) to be applied, as well as the frequency (89%), and duration (84%) of application. Of the participants, 70% were unaware of the potential risks of unsupervised TC use, 47% believed that the same TC could be shared with family, 82% had previously used topical medications without consultation, 85% had stored topical medications for future use, and 70% were unaware of the dangers associated with TCs.

Conclusion: High-potency TCs are commonly prescribed. Awareness regarding the safe use of TCs is lacking in the majority of patients receiving them. Healthcare providers need to actively educate patients regarding TCs and the impact of their misuse.

## Linked entities

- **Chemicals:** betamethasone (PubChem CID 3003)
- **Diseases:** dermatitis (MONDO:0002406)

## Full-text entities

- **Diseases:** Dermatitis (MESH:D003872)
- **Chemicals:** TCs (MESH:D013667), betamethasone (MESH:D001623), TC (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12908688/full.md

---
Source: https://tomesphere.com/paper/PMC12908688